Emtricitabine Capsule — FDA Drug Shortage

To Be Discontinued — Gilead Sciences, Inc.

The FDA lists a drug shortage record for Emtricitabine Capsule (capsule) from Gilead Sciences, Inc. with status To Be Discontinued. The shortage was first posted on Jun 17, 2026.

Shortage details

Status
To Be Discontinued
Company
Gilead Sciences, Inc.
Package NDC
61958-0601-1
Dosage Form
Capsule
Presentation
Emtriva, Capsule, 200 mg (NDC 61958-0601-1)
Initial Posting
Jun 17, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.